Nan Fung Life Sciences antes up $32M to fuel a neuro play as the Hong Kong conglomerate burns through $1.5B mandate
Having relied heavily on its Pivotal bioVentures Partners arm to make direct investments in biotech, Nan Fung Life Sciences is taking an increasingly prominent seat …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.